Asian Breast Implants Market

Asian Market Study on Breast Implants: Breast Augmentation Remains One of the Top Cosmetic Surgical Procedures Across the Asian Region

Asian Breast Implants Market Segmented By Silicone Breast Implants, Saline Breast Implants Product Type in Round Breast Implants, Anatomical Breast Implants with Cosmetic Surgery, Reconstructive Surgery

  • March-2017
  • PMRREP14785
  • 164 Pages
  • Healthcare

Cosmetic surgery segment to remain the dominant application segment in the Asian breast implants market

Cosmetic surgery segment is expected to account for more than 75% revenue share of the Asian breast implants market by 2017 end and is expected to gain more than 150 BPS in its market share over the forecast period. The cosmetic surgery segment is slated to register a CAGR of 7.4% while the reconstructive surgery segment is expected to grow at a CAGR of 6.3% over the projected period.

The reconstructive surgery segment is estimated to lose more than 150 BPS in its market share over the forecast period and reach a market valuation of more than US$ 60 Mn by 2025.

The cosmetic surgery segment is expected to dominate the Asian breast implants market in revenue terms in 2017 and this trend is projected to continue to do so throughout the forecast period. Cosmetic surgery is the most attractive application segment, recording a market attractiveness index of 1.6 over the forecast period.

The reconstructive surgery segment is likely to be the second most lucrative segment in the Asian breast implants market, with a market attractiveness index of 0.4 during the forecast period.

Find Out More about the Report Coverage


  • Allergan, Plc (Actavis Plc)
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG)
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • Others.

Rising disposable income in Asia and increasing number of women in the Asian workforce is expected to propel the growth in demand for breast implants during the projected period

Reconstructive breast surgery is usually performed in order to treat structures of the body affected functionally. Breast reconstruction after mastectomy is generally covered under Medicare resulting in the rise in a number of breast reconstruction procedures worldwide.

The rise in annual disposable income per capita of women in Asian countries is creating a positive impact on the cosmetic surgery segment of the Asian breast implants market. Socio-economic status is a prime factor creating higher demand for breast implants in Asian women. The primary customer base for breast implant procedures are women belonging to middle and high-income families.

Additionally, a significant rise in the world’s middle-class population over the next few years, resulting in an increase in purchasing power and discretionary spending are indicative of the stability and growth of the cosmetic surgery segment worldwide. Breast cancer is a leading cause of mortality worldwide particularly in less developed countries, mainly attributed to shifting lifestyles and unavailability of adequate healthcare infrastructure coupled with less penetration of clinical advancements to combat the disease. Rising prevalence of breast cancer is a major factor contributing to the revenue growth of the cosmetic and reconstructive surgery segments across the globe.

A large number of women are conscious about the physical appearance of their breasts leading to increasing number of breast augmentation procedures in developed countries such as China and Indonesia. However, some of the most common reasons for breast augmentation procedures include changing the breast size, restoring the natural appearance of the breasts, and correcting capsular contracture. This factor is likely to create robust development in the cosmetic surgery segment over the projected period.

asian breast implants market

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Increasing preference for breast augmentation procedure likely to drive patients to undergo reconstructive surgeries in Rest of Asia

Growing focus on aesthetic appearance driven by popular media influences such as television shows and various consumer awareness programs is expected to drive the market for the cosmetic surgery application segment in China; while in Malaysia, fat transfer breast augmentation procedure is anticipated to fuel the cosmetic surgery application segment in the coming years.

In Indonesia, the reconstructive surgery segment is expected to reach more than US$ 3 Mn in 2017. Cheaper cost of breast implant surgery in Thailand is predicted to boost the revenue growth of the cosmetic surgery segment over the forecast period.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Market Segmentation

By Country

  • China
  • Malaysia
  • Indonesia
  • Thailand
  • Singapore
  • Vietnam
  • Rest of Asia

By Product Type

  • Silicone Breast Implants
  • Saline Breast Implants

By Shape

  • Round Breast Implants
  • Anatomical Breast Implants

By Application

  • Cosmetic Surgery
  • Reconstructive Surgery

By End User

  • Hospitals
  • Cosmetology Clinics

Explore Persistence Market Research’s expertise in promulgation of the business !


Oncolytic Virus Immunotherapy Market

Global oncolytic virus immunotherapy market will be valued at ~ US$ 214 Mn by 2029-end, expanding at a promising CAGR of ~12% during the forecast period of 2019-2029..

Artificial Saliva Market

Global Artificial Saliva Market - check share, size, revenue, valuation, CAGR, regional outlook, key players, competitive landscape, latest trends & forecast.

Biomaterials Market

The global biomaterials market was valued at US$ 112 Bn in 2021 and is expected to reach US$ 470 Bn by 2032, advancing at a high-value CAGR of 14.5% from 2022 to 2032..

Uveitis Market

Global uveitis treatment market, which was estimated to represent more than 30% share of the total market in 2016 & is expected to expand at a CAGR of 7.3% by 2024 end.

Our Clients

Our Clients